Inhibitor Of Kappa-Light Polypeptide Gene Enhancer In B-Cells Kinase Beta (IkBKb)

IKK2; NFKBIKB; IKK-beta; IKKB; I-kappa-B kinase 2; Nuclear factor NF-kappa-B inhibitor kinase beta

SPN	N943
HGNC	5960
MGI	1338071
PubMed	15685170
RGD	621375
UniProt	O14920
Wiki	IKBKB

IKK-β also known as inhibitor of nuclear factor kappa-B kinase subunit beta is an enzyme that serves as a protein subunit of IκB kinase, which is a component of the cytokine-activated intracellular signaling pathway involved in triggering immune responses. Its activity causes activation of a transcription factor known as Nuclear Transcription factor kappa-B or NF-κB. Activated IKK-β phosphorylates a protein called the inhibitor of NF-κB, IκB (IκBα), which binds NF-κB to inhibit its function.

Phosphorylated IκB is degraded via the ubiquitination pathway, freeing NF-κB, and allowing its entry into the nucleus of the cell where it activates various genes involved in inflammation and other immune responses.IKK-β plays a significant role in brain cells following a stroke.

Reference

"IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation."
Science 278:860-866(1997) [PubMed] [Europe PMC] [Abstract]

"IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK."
Science 278:866-869(1997) [PubMed] [Europe PMC] [Abstract]

"IkappaB kinase-alpha and -beta genes are coexpressed in adult and embryonic tissues but localized to different human chromosomes."
Gene 222:31-40(1998) [PubMed] [Europe PMC] [Abstract]

"Assignment of IkappaB kinase beta (IKBKB) to human chromosome band 8p12-->p11 by in situ hybridization."
Cytogenet. Cell Genet. 82:32-33(1998) [PubMed] [Europe PMC] [Abstract]

"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]

"DNA sequence and analysis of human chromosome 8."
Nature 439:331-335(2006) [PubMed] [Europe PMC] [Abstract]

"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]

"Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling."
Proc. Natl. Acad. Sci. U.S.A. 103:18574-18579(2006) [PubMed] [Europe PMC] [Abstract]

"Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase."
Mol. Cell. Biol. 18:7336-7343(1998) [PubMed] [Europe PMC] [Abstract]

"IKAP is a scaffold protein of the IkappaB kinase complex."
Nature 395:292-296(1998) [PubMed] [Europe PMC] [Abstract]

"The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation."
EMBO J. 18:3044-3053(1999) [PubMed] [Europe PMC] [Abstract]

"Activation of IkappaB kinase beta by protein kinase C isoforms."
Mol. Cell. Biol. 19:2180-2188(1999) [PubMed] [Europe PMC] [Abstract]

"Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation."
Science 284:309-313(1999) [PubMed] [Europe PMC] [Abstract]

"PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex."
Mol. Cell. Biol. 20:4532-4542(2000) [PubMed] [Europe PMC] [Abstract]

"NAK is an IkappaB kinase-activating kinase."
Nature 404:778-782(2000) [PubMed] [Europe PMC] [Abstract]

"Direct phosphorylation of NF-kappa B1 p105 by the Ikappa B kinase complex on serine 927 is essential for signal-induced p105 proteolysis."
J. Biol. Chem. 276:22215-22222(2001) [PubMed] [Europe PMC] [Abstract]

"Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases."
J. Biol. Chem. 277:37029-37036(2002) [PubMed] [Europe PMC] [Abstract]

"Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase."
Mol. Cell. Biol. 22:3549-3561(2002) [PubMed] [Europe PMC] [Abstract]

"Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation."
Mol. Cell. Biol. 23:2029-2041(2003) [PubMed] [Europe PMC] [Abstract]

"Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways."
J. Biol. Chem. 279:15652-15661(2004) [PubMed] [Europe PMC] [Abstract]

"PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kappaB and caspase-1 activation in macrophages."
J. Biol. Chem. 279:51897-51907(2004) [PubMed] [Europe PMC] [Abstract]

"beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha."
Proc. Natl. Acad. Sci. U.S.A. 101:8603-8607(2004) [PubMed] [Europe PMC] [Abstract]

"Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation."
Proc. Natl. Acad. Sci. U.S.A. 101:8945-8950(2004) [PubMed] [Europe PMC] [Abstract]

"NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation."
J. Biol. Chem. 280:29233-29241(2005) [PubMed] [Europe PMC] [Abstract]

"3-Phosphoinositide-dependent protein kinase-1-mediated IkappaB kinase beta (IkkB) phosphorylation activates NF-kappaB signaling."
J. Biol. Chem. 280:40965-40973(2005) [PubMed] [Europe PMC] [Abstract]

"Site-specific monoubiquitination of IkappaB kinase IKKbeta regulates its phosphorylation and persistent activation."
J. Biol. Chem. 280:43272-43279(2005) [PubMed] [Europe PMC] [Abstract]

"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus."
Nature 437:1167-1172(2005) [PubMed] [Europe PMC] [Abstract]

"Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity."
Proc. Natl. Acad. Sci. U.S.A. 103:18154-18159(2006) [PubMed] [Europe PMC] [Abstract]

"Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation."
Science 312:1211-1214(2006) [PubMed] [Europe PMC] [Abstract]

"Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli."
Science 311:1141-1146(2006) [PubMed] [Europe PMC] [Abstract]

"Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1."
J. Biol. Chem. 282:10117-10131(2007) [PubMed] [Europe PMC] [Abstract]

"FAF1 suppresses IkappaB kinase (IKK) activation by disrupting the IKK complex assembly."
J. Biol. Chem. 282:27572-27577(2007) [PubMed] [Europe PMC] [Abstract]

"Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10."
Proc. Natl. Acad. Sci. U.S.A. 104:908-913(2007) [PubMed] [Europe PMC] [Abstract]

"The I kappa B/NF-kappa B system: a key determinant of mucosal inflammation and protection."
Am. J. Physiol. 278:C451-C462(2000) [PubMed] [Europe PMC] [Abstract]

"The IkappaB kinase complex: master regulator of NF-kappaB signaling."
Immunol. Res. 42:3-18(2008) [PubMed] [Europe PMC] [Abstract]

"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract]

"A quantitative atlas of mitotic phosphorylation."
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]

"Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]

"Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation."
Biochem. Biophys. Res. Commun. 389:156-161(2009) [PubMed] [Europe PMC] [Abstract]

"PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha-induced IKKbeta-NF-kappaB activation."
Cell. Signal. 21:95-102(2009) [PubMed] [Europe PMC] [Abstract]

"Large-scale proteomics analysis of the human kinome."
Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract]

"Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]

"NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways."
Cell 141:483-496(2010) [PubMed] [Europe PMC] [Abstract]

"Ro52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signalling."
J. Biochem. 146:821-832(2009) [PubMed] [Europe PMC] [Abstract]

"Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta."
J. Virol. 84:7267-7277(2010) [PubMed] [Europe PMC] [Abstract]

"Nuclear IKKbeta is an adaptor protein for IkappaBalpha ubiquitination and degradation in UV-induced NF-kappaB activation."
Mol. Cell 39:570-582(2010) [PubMed] [Europe PMC] [Abstract]

"Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]

"Initial characterization of the human central proteome."
BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]

"Novel cross-talk within the IKK family controls innate immunity."
Biochem. J. 434:93-104(2011) [PubMed] [Europe PMC] [Abstract]

"The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-kappaB signaling."
J. Biol. Chem. 287:42856-42866(2012) [PubMed] [Europe PMC] [Abstract]

"IKKepsilon-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex."
Cell Rep. 3:724-733(2013) [PubMed] [Europe PMC] [Abstract]

"Deficiency of innate and acquired immunity caused by an IKBKB mutation."
N. Engl. J. Med. 369:2504-2514(2013) [PubMed] [Europe PMC] [Abstract]

"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."
J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]

"Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site."
Structure 16:798-808(2008) [PubMed] [Europe PMC] [Abstract]

"The consensus coding sequences of human breast and colorectal cancers."
Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract]

"Patterns of somatic mutation in human cancer genomes."
Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract]